Clinical characteristics of immunoglobulin G4–related disease: a prospective study of 118 Chinese patients
To characterize the clinical features of IgG4-related disease (IgG4-RD) in China. A prospective cohort study of IgG4-RD was carried out in Peking Union Medical College Hospital between 2011 and 2013. Patients with newly diagnosed IgG4-RD were enrolled. A total of 118 patients with IgG4-RD were enrol...
Saved in:
Published in | Rheumatology (Oxford, England) Vol. 54; no. 11; pp. 1982 - 1990 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
01.11.2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | To characterize the clinical features of IgG4-related disease (IgG4-RD) in China.
A prospective cohort study of IgG4-RD was carried out in Peking Union Medical College Hospital between 2011 and 2013. Patients with newly diagnosed IgG4-RD were enrolled.
A total of 118 patients with IgG4-RD were enrolled, including 82 males and 36 females, aged 53.1 (s.d. 13.6) years. The most common symptom at onset was lacrimal gland swelling (38/32.2%). A range of organs were involved: 77 patients (65.3%) had lymphadenopathy, 76 (64.4%) had sialadenitis, 60 (50.8%) had dacryoadenitis, 45 (38.1%) had autoimmune pancreatitis, 32 (27.1%) had pulmonary involvement, 31 (26.3%) had periaortitis/retroperitoneal fibrosis, 29 (35.4% of male patients) had prostatitis and 29 (24.6%) had renal involvement. In addition, there were 21 (17.8%) cases of sclerosing cholangitis, 15 (12.7%) of sinusitis and 10 (8.5%) of inflammatory pseudotumour. Uncommon manifestations included mediastinal fibrosis, skin involvement, sclerosing thyroiditis, hypophysitis, orchitis and colitis. Multiple organ involvement was observed in 93 patients, whereas only 4.2% had only a single organ involved. A history of allergy was reported in 73 (61.9%) patients. The serum IgG4 level was elevated in 97.5% and was correlated with the number of organs involved. Most patients were treated with glucocorticoids alone or in combination with immunosuppressive drugs, and the majority usually improved within 3 months.
IgG4-RD is a systemic inflammatory and sclerosing disease. Parotid and lacrimal involvement (formerly called Mikulicz's disease), lymphadenopathy and pancreatitis are the most common manifestations. Patients with IgG4-RD showed favourable responses to treatment with glucocorticoids and immunosuppressive agents. |
---|---|
AbstractList | OBJECTIVETo characterize the clinical features of IgG4-related disease (IgG4-RD) in China.METHODSA prospective cohort study of IgG4-RD was carried out in Peking Union Medical College Hospital between 2011 and 2013. Patients with newly diagnosed IgG4-RD were enrolled.RESULTSA total of 118 patients with IgG4-RD were enrolled, including 82 males and 36 females, aged 53.1 (s.d. 13.6) years. The most common symptom at onset was lacrimal gland swelling (38/32.2%). A range of organs were involved: 77 patients (65.3%) had lymphadenopathy, 76 (64.4%) had sialadenitis, 60 (50.8%) had dacryoadenitis, 45 (38.1%) had autoimmune pancreatitis, 32 (27.1%) had pulmonary involvement, 31 (26.3%) had periaortitis/retroperitoneal fibrosis, 29 (35.4% of male patients) had prostatitis and 29 (24.6%) had renal involvement. In addition, there were 21 (17.8%) cases of sclerosing cholangitis, 15 (12.7%) of sinusitis and 10 (8.5%) of inflammatory pseudotumour. Uncommon manifestations included mediastinal fibrosis, skin involvement, sclerosing thyroiditis, hypophysitis, orchitis and colitis. Multiple organ involvement was observed in 93 patients, whereas only 4.2% had only a single organ involved. A history of allergy was reported in 73 (61.9%) patients. The serum IgG4 level was elevated in 97.5% and was correlated with the number of organs involved. Most patients were treated with glucocorticoids alone or in combination with immunosuppressive drugs, and the majority usually improved within 3 months.CONCLUSIONIgG4-RD is a systemic inflammatory and sclerosing disease. Parotid and lacrimal involvement (formerly called Mikulicz's disease), lymphadenopathy and pancreatitis are the most common manifestations. Patients with IgG4-RD showed favourable responses to treatment with glucocorticoids and immunosuppressive agents. To characterize the clinical features of IgG4-related disease (IgG4-RD) in China. A prospective cohort study of IgG4-RD was carried out in Peking Union Medical College Hospital between 2011 and 2013. Patients with newly diagnosed IgG4-RD were enrolled. A total of 118 patients with IgG4-RD were enrolled, including 82 males and 36 females, aged 53.1 (s.d. 13.6) years. The most common symptom at onset was lacrimal gland swelling (38/32.2%). A range of organs were involved: 77 patients (65.3%) had lymphadenopathy, 76 (64.4%) had sialadenitis, 60 (50.8%) had dacryoadenitis, 45 (38.1%) had autoimmune pancreatitis, 32 (27.1%) had pulmonary involvement, 31 (26.3%) had periaortitis/retroperitoneal fibrosis, 29 (35.4% of male patients) had prostatitis and 29 (24.6%) had renal involvement. In addition, there were 21 (17.8%) cases of sclerosing cholangitis, 15 (12.7%) of sinusitis and 10 (8.5%) of inflammatory pseudotumour. Uncommon manifestations included mediastinal fibrosis, skin involvement, sclerosing thyroiditis, hypophysitis, orchitis and colitis. Multiple organ involvement was observed in 93 patients, whereas only 4.2% had only a single organ involved. A history of allergy was reported in 73 (61.9%) patients. The serum IgG4 level was elevated in 97.5% and was correlated with the number of organs involved. Most patients were treated with glucocorticoids alone or in combination with immunosuppressive drugs, and the majority usually improved within 3 months. IgG4-RD is a systemic inflammatory and sclerosing disease. Parotid and lacrimal involvement (formerly called Mikulicz's disease), lymphadenopathy and pancreatitis are the most common manifestations. Patients with IgG4-RD showed favourable responses to treatment with glucocorticoids and immunosuppressive agents. |
Author | Peng, Linyi Yan, Linyi Wang, Li Zhang, Xuan Liu, Jinjing Zhang, Fengchun Zheng, Wenjie Hou, Yong Lin, Wei Shen, Min Shi, Qun Zhou, Jiaxin Zhang, Shangzhu You, Xin Jiao, Yang Li, Yongzhe Zeng, Xuejun Chen, Hua Zhang, Wen Zhang, Haiting Deng, Chuiwen Lipsky, Peter E. Yang, Yunjiao Sha, Yue Wang, Yu Li, Mengtao Li, Ping Li, Jing Su, Jinmei Xu, Dong Fei, Yunyun Wu, Di Zhang, Shulan Lu, Sha Tian, Xinping Wu, Qingjun Jiang, Ying Zeng, Xiaofeng Wu, Chanyuan Wang, Qian Huang, Xiaoming Zhao, Yan Leng, Xiaomei Zhao, Lidan Hu, Chaojun |
Author_xml | – sequence: 1 givenname: Wei surname: Lin fullname: Lin, Wei – sequence: 2 givenname: Sha surname: Lu fullname: Lu, Sha – sequence: 3 givenname: Hua surname: Chen fullname: Chen, Hua – sequence: 4 givenname: Qingjun surname: Wu fullname: Wu, Qingjun – sequence: 5 givenname: Yunyun surname: Fei fullname: Fei, Yunyun – sequence: 6 givenname: Mengtao surname: Li fullname: Li, Mengtao – sequence: 7 givenname: Xuan surname: Zhang fullname: Zhang, Xuan – sequence: 8 givenname: Xinping surname: Tian fullname: Tian, Xinping – sequence: 9 givenname: Wenjie surname: Zheng fullname: Zheng, Wenjie – sequence: 10 givenname: Xiaomei surname: Leng fullname: Leng, Xiaomei – sequence: 11 givenname: Dong surname: Xu fullname: Xu, Dong – sequence: 12 givenname: Qian surname: Wang fullname: Wang, Qian – sequence: 13 givenname: Min surname: Shen fullname: Shen, Min – sequence: 14 givenname: Li surname: Wang fullname: Wang, Li – sequence: 15 givenname: Jing surname: Li fullname: Li, Jing – sequence: 16 givenname: Di surname: Wu fullname: Wu, Di – sequence: 17 givenname: Lidan surname: Zhao fullname: Zhao, Lidan – sequence: 18 givenname: Chanyuan surname: Wu fullname: Wu, Chanyuan – sequence: 19 givenname: Yunjiao surname: Yang fullname: Yang, Yunjiao – sequence: 20 givenname: Linyi surname: Peng fullname: Peng, Linyi – sequence: 21 givenname: Jiaxin surname: Zhou fullname: Zhou, Jiaxin – sequence: 22 givenname: Yu surname: Wang fullname: Wang, Yu – sequence: 23 givenname: Yue surname: Sha fullname: Sha, Yue – sequence: 24 givenname: Xiaoming surname: Huang fullname: Huang, Xiaoming – sequence: 25 givenname: Yang surname: Jiao fullname: Jiao, Yang – sequence: 26 givenname: Xuejun surname: Zeng fullname: Zeng, Xuejun – sequence: 27 givenname: Qun surname: Shi fullname: Shi, Qun – sequence: 28 givenname: Ping surname: Li fullname: Li, Ping – sequence: 29 givenname: Shulan surname: Zhang fullname: Zhang, Shulan – sequence: 30 givenname: Chaojun surname: Hu fullname: Hu, Chaojun – sequence: 31 givenname: Chuiwen surname: Deng fullname: Deng, Chuiwen – sequence: 32 givenname: Yongzhe surname: Li fullname: Li, Yongzhe – sequence: 33 givenname: Shangzhu surname: Zhang fullname: Zhang, Shangzhu – sequence: 34 givenname: Jinjing surname: Liu fullname: Liu, Jinjing – sequence: 35 givenname: Jinmei surname: Su fullname: Su, Jinmei – sequence: 36 givenname: Yong surname: Hou fullname: Hou, Yong – sequence: 37 givenname: Ying surname: Jiang fullname: Jiang, Ying – sequence: 38 givenname: Xin surname: You fullname: You, Xin – sequence: 39 givenname: Haiting surname: Zhang fullname: Zhang, Haiting – sequence: 40 givenname: Linyi surname: Yan fullname: Yan, Linyi – sequence: 41 givenname: Wen surname: Zhang fullname: Zhang, Wen – sequence: 42 givenname: Yan surname: Zhao fullname: Zhao, Yan – sequence: 43 givenname: Xiaofeng surname: Zeng fullname: Zeng, Xiaofeng – sequence: 44 givenname: Fengchun surname: Zhang fullname: Zhang, Fengchun – sequence: 45 givenname: Peter E. surname: Lipsky fullname: Lipsky, Peter E. |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26106212$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kUtOwzAQhi0EolA4ARLykk2oX40TdqjiJVViA-vItSetwYmL7SB1xx24ISchVUuFWLCaWXzfaGb-Y7Tf-hYQOqPkkpKSj8ICukYl7_x8NXqFd0b4HjqiImcZ4Zzt73omBug4xhdCyJjy4hANWE5Jzig7Qm7ibGu1clgvVFA6QbAxWR2xr7Ftmq71c-dnXU_hO_H18RnAqQQGGxtBRbjCCi-Dj0vQyb4Djqkzq7VLaYEnC9tCBLxUyUKb4gk6qJWLcLqtQ_R8e_M0uc-mj3cPk-tppoWgKZNM5GNaQ6nHBeUSQNazWud8LDlVM6MVYZqpUheFFtJwZqCujZGiUFIWRJd8iC42c_vN3jqIqWps1OCcasF3saKSMUHLIpc9er5Fu1kDploG26iwqn4-1AN8A-j-yhig3iGUVOscqt85VJsceqv8Y2mb-i_4NgVl3b_uN8Orlzc |
CitedBy_id | crossref_primary_10_1016_j_remnie_2021_02_002 crossref_primary_10_1007_s00296_017_3730_5 crossref_primary_10_5582_irdr_2018_01075 crossref_primary_10_1080_14397595_2018_1554321 crossref_primary_10_3171_2016_5_SPINE16119 crossref_primary_10_1016_j_jbspin_2018_01_014 crossref_primary_10_1080_14397595_2016_1233929 crossref_primary_10_1111_odi_13926 crossref_primary_10_1080_14397595_2019_1572575 crossref_primary_10_1016_j_rcreu_2021_04_010 crossref_primary_10_1007_s10067_024_07276_w crossref_primary_10_1016_j_berh_2016_07_003 crossref_primary_10_1186_s13075_020_02338_1 crossref_primary_10_1093_mr_roac065 crossref_primary_10_1210_clinem_dgab672 crossref_primary_10_1136_bjo_2021_320936 crossref_primary_10_4103_cdr_cdr_90_21 crossref_primary_10_1093_rheumatology_keaa775 crossref_primary_10_1093_rheumatology_keaa411 crossref_primary_10_1111_aos_14048 crossref_primary_10_1097_MPA_0000000000001558 crossref_primary_10_3390_ijms241813735 crossref_primary_10_1001_jamadermatol_2019_4260 crossref_primary_10_1016_j_medcle_2019_10_020 crossref_primary_10_1186_s12882_021_02477_w crossref_primary_10_1016_j_wneu_2022_12_108 crossref_primary_10_1177_20406223211028776 crossref_primary_10_18786_2072_0505_2020_48_010 crossref_primary_10_1016_j_ajoc_2020_100789 crossref_primary_10_1016_j_medcli_2019_10_026 crossref_primary_10_1111_joim_12942 crossref_primary_10_1038_nrgastro_2016_132 crossref_primary_10_1016_j_jfo_2023_04_007 crossref_primary_10_1007_s00428_021_03216_0 crossref_primary_10_1016_j_heliyon_2023_e23433 crossref_primary_10_1007_s13760_021_01844_6 crossref_primary_10_1093_mrcr_rxae083 crossref_primary_10_1016_j_amjms_2017_08_014 crossref_primary_10_1093_rheumatology_keaa648 crossref_primary_10_1007_s12016_016_8584_1 crossref_primary_10_3390_life13081725 crossref_primary_10_1016_j_jns_2021_117420 crossref_primary_10_1177_11206721221102274 crossref_primary_10_1007_s12020_021_02714_0 crossref_primary_10_1186_s13075_021_02627_3 crossref_primary_10_4103_0366_6999_184459 crossref_primary_10_2169_naika_110_962 crossref_primary_10_1016_j_semarthrit_2019_05_003 crossref_primary_10_1080_14397595_2018_1546367 crossref_primary_10_1111_bpa_12459 crossref_primary_10_1136_bmj_m1067 crossref_primary_10_25259_JSSTD_52_2019 crossref_primary_10_1136_rmdopen_2022_002521 crossref_primary_10_1016_j_gtc_2017_01_001 crossref_primary_10_1111_1756_185X_13088 crossref_primary_10_1111_imj_13430 crossref_primary_10_1016_j_ijom_2023_01_007 crossref_primary_10_1186_s12890_020_01250_3 crossref_primary_10_3343_alm_2023_43_5_461 crossref_primary_10_1016_j_waojou_2023_100864 crossref_primary_10_1080_1744666X_2019_1560268 crossref_primary_10_1186_s12882_020_02223_8 crossref_primary_10_1002_pros_23684 crossref_primary_10_1007_s10067_020_05135_y crossref_primary_10_1007_s10067_020_05097_1 crossref_primary_10_1053_j_gastro_2018_06_082 crossref_primary_10_1111_joim_13814 crossref_primary_10_2147_CCID_S406199 crossref_primary_10_1016_j_ekir_2018_08_011 crossref_primary_10_1155_2018_7637435 crossref_primary_10_1016_j_jtauto_2020_100074 crossref_primary_10_1111_jne_12942 crossref_primary_10_1016_j_autrev_2021_102805 crossref_primary_10_1186_s13075_019_2090_9 crossref_primary_10_3390_biomedicines11082287 crossref_primary_10_7759_cureus_17940 crossref_primary_10_1093_mr_roac132 crossref_primary_10_1007_s12016_021_08887_w crossref_primary_10_1002_ccr3_7865 crossref_primary_10_1093_ajcp_aqaa258 crossref_primary_10_1097_CU9_0000000000000097 crossref_primary_10_1093_rheumatology_kez667 crossref_primary_10_1186_s12882_019_1419_6 crossref_primary_10_1097_MD_0000000000006205 crossref_primary_10_1186_s13075_017_1467_x crossref_primary_10_47360_1995_4484_2020_368_375 crossref_primary_10_1177_2050640620934911 crossref_primary_10_1371_journal_pone_0183844 crossref_primary_10_1016_j_ccm_2019_05_005 crossref_primary_10_1007_s00296_024_05611_7 crossref_primary_10_1186_s13075_017_1507_6 crossref_primary_10_1016_j_wneu_2020_07_227 crossref_primary_10_1111_1756_185X_13949 crossref_primary_10_1007_s12026_019_9070_7 crossref_primary_10_26442_00403660_2019_05_000236 crossref_primary_10_1053_j_semvascsurg_2023_04_019 crossref_primary_10_3389_fimmu_2022_825386 crossref_primary_10_1016_S1773_035X_16_30225_8 crossref_primary_10_1016_j_waojou_2023_100765 crossref_primary_10_1002_ccr3_6324 crossref_primary_10_1080_17446651_2019_1598260 crossref_primary_10_1097_RHU_0000000000000705 crossref_primary_10_1007_s11940_017_0450_9 crossref_primary_10_1016_j_remn_2020_12_001 crossref_primary_10_1007_s00428_024_03757_0 crossref_primary_10_1097_RHU_0000000000002057 crossref_primary_10_1016_j_reuma_2022_11_006 crossref_primary_10_1186_s12890_019_0785_y crossref_primary_10_1002_rcr2_958 crossref_primary_10_5530_ami_2016_1_44 crossref_primary_10_1016_j_ehpc_2018_05_005 crossref_primary_10_1212_NXI_0000000000000568 crossref_primary_10_1016_j_amjmed_2020_04_040 crossref_primary_10_1186_s13075_018_1567_2 crossref_primary_10_1016_j_cdtm_2017_05_003 crossref_primary_10_1007_s11596_021_2359_5 crossref_primary_10_1016_j_radcr_2016_10_008 crossref_primary_10_1186_s13075_017_1231_2 crossref_primary_10_1016_j_anl_2023_10_006 crossref_primary_10_1007_s11154_018_9480_1 crossref_primary_10_1016_j_rhum_2019_03_010 crossref_primary_10_1186_s12905_022_01968_8 crossref_primary_10_1016_j_gtc_2019_02_008 crossref_primary_10_1155_2023_2742839 crossref_primary_10_1007_s11102_016_0736_z crossref_primary_10_1016_j_amjms_2020_05_031 crossref_primary_10_1016_j_autrev_2022_103035 crossref_primary_10_3389_fimmu_2022_1077609 crossref_primary_10_1111_ijd_13369 crossref_primary_10_1038_s41575_021_00529_y crossref_primary_10_1016_j_revmed_2020_06_015 crossref_primary_10_12677_acm_2024_1451403 crossref_primary_10_1097_RHU_0000000000001895 crossref_primary_10_1159_000480297 crossref_primary_10_1038_s41598_020_61585_z crossref_primary_10_1186_s13075_022_02792_z crossref_primary_10_3390_endocrines2020016 crossref_primary_10_1016_j_semarthrit_2023_152202 crossref_primary_10_1016_j_beem_2019_04_010 crossref_primary_10_1016_j_jvs_2022_12_024 crossref_primary_10_1155_2021_1959832 crossref_primary_10_1007_s11102_021_01180_1 crossref_primary_10_1016_j_autrev_2016_12_008 crossref_primary_10_1016_j_rcreue_2021_04_007 crossref_primary_10_1016_j_path_2023_01_002 crossref_primary_10_1186_s40792_021_01151_5 crossref_primary_10_1080_14397595_2020_1859710 crossref_primary_10_1017_S0022215118002153 crossref_primary_10_1038_s41598_018_28405_x crossref_primary_10_5114_reum_2016_63667 crossref_primary_10_1097_PAI_0000000000001040 crossref_primary_10_1007_s11102_018_00930_y crossref_primary_10_1186_s13023_022_02404_8 crossref_primary_10_1186_s13075_024_03391_w crossref_primary_10_1016_j_athoracsur_2017_09_018 crossref_primary_10_1111_1759_7714_12914 crossref_primary_10_1016_j_reumae_2023_05_001 crossref_primary_10_1007_s10238_023_01123_z crossref_primary_10_1111_1756_185X_12863 crossref_primary_10_1155_2018_4057024 crossref_primary_10_1155_2020_5851842 crossref_primary_10_1080_25785826_2024_2430812 crossref_primary_10_7759_cureus_47099 crossref_primary_10_1038_s41598_017_06520_5 |
Cites_doi | 10.1136/ard.2008.089169 10.1038/ki.2013.191 10.1186/ar4571 10.2214/AJR.12.9995 10.3109/03009742.2013.822094 10.1016/j.autrev.2010.05.003 10.1007/s10165-011-0508-6 10.1111/j.1365-2222.2009.03207.x 10.1111/j.1572-0241.2003.08758.x 10.1016/j.anndiagpath.2013.04.010 10.1007/s00535-006-1908-9 10.1016/j.autrev.2004.10.005 10.1056/NEJMra1104650 10.1007/s00259-014-2729-3 10.5402/2011/873087 10.1097/MD.0b013e3182433d77 10.1093/rheumatology/ket182 10.1111/all.12320 10.1159/000336706 10.1016/j.asjsur.2012.04.013 10.1056/NEJM200103083441005 10.1053/j.semdp.2012.08.002 10.1097/MNH.0b013e32835265ac 10.1111/all.12342 10.1007/s12016-014-8430-2 10.1097/PAS.0b013e3181f7266b 10.1038/modpathol.2013.236 10.1164/rccm.201306-1121ED 10.1002/art.33320 10.1016/j.jjcc.2011.10.005 10.1002/lary.22449 10.1016/j.jbspin.2014.01.010 10.1093/rheumatology/keu228 10.1183/09031936.00025211 10.1007/s10165-011-0571-z |
ContentType | Journal Article |
Copyright | The Author 2015. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
Copyright_xml | – notice: The Author 2015. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1093/rheumatology/kev203 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1462-0332 |
EndPage | 1990 |
ExternalDocumentID | 26106212 10_1093_rheumatology_kev203 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | China |
GeographicLocations_xml | – name: China |
GroupedDBID | --- -E4 .2P .GJ .I3 .XZ .ZR 08P 0R~ 18M 1TH 29P 2WC 354 3O- 4.4 48X 53G 5RE 5VS 5WA 5WD 70D AABZA AACZT AAGKA AAJKP AAJQQ AAMDB AAMVS AAOGV AAPGJ AAPNW AAPQZ AAPXW AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL AAYXX ABDFA ABEJV ABEUO ABGNP ABIXL ABJNI ABKDP ABLJU ABNGD ABNHQ ABNKS ABOCM ABPTD ABQLI ABQNK ABVGC ABXVV ABZBJ ACFRR ACGFO ACGFS ACPRK ACUFI ACUKT ACUTJ ACUTO ACYHN ADBBV ADEYI ADEZT ADGZP ADHKW ADHZD ADIPN ADMTO ADNBA ADOCK ADQBN ADRTK ADVEK ADYVW ADZXQ AEGPL AEGXH AEHUL AEJOX AEKSI AEMDU AEMQT AENEX AENZO AEPUE AETBJ AEWNT AFFNX AFFZL AFIYH AFOFC AFXAL AGINJ AGKEF AGORE AGQPQ AGSYK AGUTN AHGBF AHMBA AHMMS AHXPO AIAGR AIJHB AJBYB AJEEA AJNCP AKWXX ALMA_UNASSIGNED_HOLDINGS ALUQC ALXQX APIBT APWMN AQDSO ATGXG ATTQO AXUDD AZFZN BAWUL BAYMD BCRHZ BEYMZ BHONS BTRTY BVRKM C45 CAG CDBKE CITATION COF CS3 CZ4 DAKXR DIK DILTD DU5 D~K E3Z EBD EBS EE~ EIHJH EJD EMOBN ENERS F5P F9B FECEO FEDTE FLUFQ FOEOM FOTVD FQBLK GAUVT GJXCC GX1 H13 H5~ HAR HVGLF HW0 HZ~ IOX J21 JXSIZ KAQDR KBUDW KOP KQ8 KSI KSN L7B M-Z MHKGH N9A NGC NOMLY NOYVH NTWIH NU- NVLIB O0~ O9- OAUYM OAWHX OBH OCZFY ODMLO OHH OJQWA OJZSN OPAEJ OVD OWPYF O~Y P2P PAFKI PB- PEELM PQQKQ Q1. Q5Y R44 RD5 RIG RNI ROL ROX RUSNO RW1 RXO RZF RZO SV3 TCURE TEORI TJX TMA TR2 VVN W8F WOQ X7H YAYTL YKOAZ YXANX ZGI ZKX ZY1 ~91 ABQTQ CGR CUY CVF ECM EIF M49 NPM 7X8 |
ID | FETCH-LOGICAL-c441t-724651fe9c58137ee7fbfc635731abdca02c2a9c88c47d32deffdd748a7780c93 |
ISSN | 1462-0324 |
IngestDate | Fri Jul 11 11:53:52 EDT 2025 Thu Apr 03 07:08:21 EDT 2025 Tue Jul 01 01:36:34 EDT 2025 Thu Apr 24 23:20:41 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 11 |
Keywords | IgG4 autoimmune pancreatitis prospective cohort IgG4-related disease Mikulicz’s disease |
Language | English |
License | The Author 2015. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c441t-724651fe9c58137ee7fbfc635731abdca02c2a9c88c47d32deffdd748a7780c93 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 26106212 |
PQID | 1722419867 |
PQPubID | 23479 |
PageCount | 9 |
ParticipantIDs | proquest_miscellaneous_1722419867 pubmed_primary_26106212 crossref_primary_10_1093_rheumatology_kev203 crossref_citationtrail_10_1093_rheumatology_kev203 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2015-11-01 |
PublicationDateYYYYMMDD | 2015-11-01 |
PublicationDate_xml | – month: 11 year: 2015 text: 2015-11-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England |
PublicationTitle | Rheumatology (Oxford, England) |
PublicationTitleAlternate | Rheumatology (Oxford) |
PublicationYear | 2015 |
References | 2015101306572524000_54.11.1982.20 2015101306572524000_54.11.1982.21 2015101306572524000_54.11.1982.22 2015101306572524000_54.11.1982.23 2015101306572524000_54.11.1982.24 2015101306572524000_54.11.1982.25 2015101306572524000_54.11.1982.26 2015101306572524000_54.11.1982.27 2015101306572524000_54.11.1982.28 2015101306572524000_54.11.1982.29 2015101306572524000_54.11.1982.30 Ebbo (2015101306572524000_54.11.1982.2) 2013; 63 2015101306572524000_54.11.1982.31 2015101306572524000_54.11.1982.10 2015101306572524000_54.11.1982.32 2015101306572524000_54.11.1982.11 2015101306572524000_54.11.1982.33 2015101306572524000_54.11.1982.34 Rollins (2015101306572524000_54.11.1982.12) 2011; 2011 2015101306572524000_54.11.1982.1 2015101306572524000_54.11.1982.4 2015101306572524000_54.11.1982.5 2015101306572524000_54.11.1982.8 2015101306572524000_54.11.1982.13 2015101306572524000_54.11.1982.35 2015101306572524000_54.11.1982.9 2015101306572524000_54.11.1982.14 2015101306572524000_54.11.1982.36 2015101306572524000_54.11.1982.6 2015101306572524000_54.11.1982.15 2015101306572524000_54.11.1982.37 2015101306572524000_54.11.1982.7 2015101306572524000_54.11.1982.16 2015101306572524000_54.11.1982.38 2015101306572524000_54.11.1982.17 2015101306572524000_54.11.1982.18 2015101306572524000_54.11.1982.19 Hirabayashi (2015101306572524000_54.11.1982.3) 2012; 104 |
References_xml | – ident: 2015101306572524000_54.11.1982.26 doi: 10.1136/ard.2008.089169 – ident: 2015101306572524000_54.11.1982.18 doi: 10.1038/ki.2013.191 – ident: 2015101306572524000_54.11.1982.31 doi: 10.1186/ar4571 – ident: 2015101306572524000_54.11.1982.16 doi: 10.2214/AJR.12.9995 – ident: 2015101306572524000_54.11.1982.23 doi: 10.3109/03009742.2013.822094 – ident: 2015101306572524000_54.11.1982.7 doi: 10.1016/j.autrev.2010.05.003 – ident: 2015101306572524000_54.11.1982.9 doi: 10.1007/s10165-011-0508-6 – ident: 2015101306572524000_54.11.1982.32 doi: 10.1111/j.1365-2222.2009.03207.x – ident: 2015101306572524000_54.11.1982.4 doi: 10.1136/ard.2008.089169 – volume: 63 start-page: 605 year: 2013 ident: 2015101306572524000_54.11.1982.2 article-title: [IgG4-related disease] publication-title: Rev Prat – ident: 2015101306572524000_54.11.1982.6 doi: 10.1111/j.1572-0241.2003.08758.x – ident: 2015101306572524000_54.11.1982.19 doi: 10.1016/j.anndiagpath.2013.04.010 – ident: 2015101306572524000_54.11.1982.33 doi: 10.1007/s00535-006-1908-9 – volume: 104 start-page: 43 year: 2012 ident: 2015101306572524000_54.11.1982.3 article-title: IgG4-related disease publication-title: Pathologica – ident: 2015101306572524000_54.11.1982.8 doi: 10.1016/j.autrev.2004.10.005 – ident: 2015101306572524000_54.11.1982.1 doi: 10.1056/NEJMra1104650 – ident: 2015101306572524000_54.11.1982.35 doi: 10.1007/s00259-014-2729-3 – volume: 2011 start-page: 873087 year: 2011 ident: 2015101306572524000_54.11.1982.12 article-title: Gastric IgG4-related autoimmune fibrosclerosing pseudotumour: a novel location publication-title: ISRN Gastroenterol doi: 10.5402/2011/873087 – ident: 2015101306572524000_54.11.1982.25 doi: 10.1097/MD.0b013e3182433d77 – ident: 2015101306572524000_54.11.1982.34 doi: 10.1093/rheumatology/ket182 – ident: 2015101306572524000_54.11.1982.27 doi: 10.1111/all.12320 – ident: 2015101306572524000_54.11.1982.15 doi: 10.1159/000336706 – ident: 2015101306572524000_54.11.1982.21 doi: 10.1016/j.asjsur.2012.04.013 – ident: 2015101306572524000_54.11.1982.5 doi: 10.1056/NEJM200103083441005 – ident: 2015101306572524000_54.11.1982.37 doi: 10.1053/j.semdp.2012.08.002 – ident: 2015101306572524000_54.11.1982.14 doi: 10.1097/MNH.0b013e32835265ac – ident: 2015101306572524000_54.11.1982.30 doi: 10.1111/all.12342 – ident: 2015101306572524000_54.11.1982.20 doi: 10.1007/s12016-014-8430-2 – ident: 2015101306572524000_54.11.1982.24 doi: 10.1097/PAS.0b013e3181f7266b – ident: 2015101306572524000_54.11.1982.28 doi: 10.1038/modpathol.2013.236 – ident: 2015101306572524000_54.11.1982.17 doi: 10.1164/rccm.201306-1121ED – ident: 2015101306572524000_54.11.1982.29 doi: 10.1002/art.33320 – ident: 2015101306572524000_54.11.1982.10 doi: 10.1016/j.jjcc.2011.10.005 – ident: 2015101306572524000_54.11.1982.11 doi: 10.1002/lary.22449 – ident: 2015101306572524000_54.11.1982.36 doi: 10.1016/j.jbspin.2014.01.010 – ident: 2015101306572524000_54.11.1982.38 doi: 10.1093/rheumatology/keu228 – ident: 2015101306572524000_54.11.1982.13 doi: 10.1183/09031936.00025211 – ident: 2015101306572524000_54.11.1982.22 doi: 10.1007/s10165-011-0571-z |
SSID | ssj0005138 |
Score | 2.553059 |
Snippet | To characterize the clinical features of IgG4-related disease (IgG4-RD) in China.
A prospective cohort study of IgG4-RD was carried out in Peking Union Medical... OBJECTIVETo characterize the clinical features of IgG4-related disease (IgG4-RD) in China.METHODSA prospective cohort study of IgG4-RD was carried out in... |
SourceID | proquest pubmed crossref |
SourceType | Aggregation Database Index Database Enrichment Source |
StartPage | 1982 |
SubjectTerms | Adult Aged Aged, 80 and over Asian Continental Ancestry Group China - epidemiology Cohort Studies Drug Therapy, Combination Female Glucocorticoids - therapeutic use Humans Immunoglobulin G Immunosuppressive Agents - therapeutic use Incidence Lymphatic Diseases - epidemiology Lymphatic Diseases - etiology Male Middle Aged Mikulicz' Disease - epidemiology Mikulicz' Disease - etiology Pancreatitis - epidemiology Pancreatitis - etiology Prospective Studies Retrospective Studies Scleroderma, Systemic - complications Scleroderma, Systemic - drug therapy Scleroderma, Systemic - immunology Treatment Outcome |
Title | Clinical characteristics of immunoglobulin G4–related disease: a prospective study of 118 Chinese patients |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26106212 https://www.proquest.com/docview/1722419867 |
Volume | 54 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3bbtQwELWWIiFeULkvUGQkHkmb2E4c84aq0uVSJFAr-hY5jqOCqizqbiTEE__Qj-C_-BLGt8S7QEV5iXatZKLsnJ1LPHMGoaeiybhsaJGA_a0T1rYskeAokwLwpGrCwCeZbuSDd8XsiL0-zo8nkx9R1VK_rLfVtz_2lfyPVmEN9Gq6ZC-h2UEoLMBn0C8cQcNw_Ccd74a2RrVGu2x4IEzjx9zwfdha830WyhqobV-BONPvzbh2ZzCkoenSUc4aGZAW2AHbeqEDAesijmY_nOgeIl5H42R4S7-GUnk_GyR6z_DWkRV81J-Gld6-ej0Za4V8p8isH32FPec9-NfPfRe_ochy36o3GlVWkCSlrld6W8drdMUSOzrpgLgssquZcCOKvI_OhJsx-pv9d9xYZ9HTw1fQHknp6PDCJv-aHxyqE92-PK1iMZUTcgVdJZCP2Nz91ZuxliizI9OHBw30VoLuxEJ2nJDVEOgveY2Nbw430Q2fmOAXDmU30UR3t9C1A196cRudBrDhNbDheYtXwYb32c_v5x5m2MPsOZY4Ahm2IDPXAsiwBxkOILuDjl7uHe7OEj-qI1EQTy8TTliRZ60WKi8zyrXmbd0qw3VIM1k3SqZEESlUWSrGG0oa3bZNw1kpOS9TJehdtNHNO30fYSppWSjTf8klE2les1JJCHLzJi1IW4spIuHXq5TnsTfjVE6rC_Q2Rc-Gi744GpeLT38S1FKBuTV7aLLT835RQbwPMa8oCz5F95y-BoEEUpECQsEHl7vZQ3R9_Nc8QhvLs15vQaS7rB9blP0CkiCxuw |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+characteristics+of+immunoglobulin+G4%E2%80%93related+disease%3A+a+prospective+study+of+118+Chinese+patients&rft.jtitle=Rheumatology+%28Oxford%2C+England%29&rft.au=Lin%2C+Wei&rft.au=Lu%2C+Sha&rft.au=Chen%2C+Hua&rft.au=Wu%2C+Qingjun&rft.date=2015-11-01&rft.issn=1462-0324&rft.eissn=1462-0332&rft.volume=54&rft.issue=11&rft.spage=1982&rft.epage=1990&rft_id=info:doi/10.1093%2Frheumatology%2Fkev203&rft.externalDBID=n%2Fa&rft.externalDocID=10_1093_rheumatology_kev203 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1462-0324&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1462-0324&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1462-0324&client=summon |